Hello and Welcome to Patientsville.com, Your Source for all DIPRIVAN information. We are dedicated to provide You with DIPRIVAN safety information. Learn about DIPRIVAN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
DIPRIVAN Safety Reports
Total DIPRIVAN reports: 142.DIPRIVAN FDA safety alerts: 2001 2007 .
Reported deaths: 23 Reported hospitalizations: 44.
Take DIPRIVAN Side Effects Survey or Share Your DIPRIVAN Story. Read More Here.
Showing 1-75 of 142 Next >
Consumer or non-health professional from UNITED STATES reported DIPRIVAN problem on Aug 29, 2006. Male patient, child 3 years of age, was treated with DIPRIVAN. DIPRIVAN dosage: unknown. Patient died on 01/01/2002.DIPRIVAN problem was reported by a Physician from JAPAN on Apr 18, 2006. Female patient, 74 years of age, weighting 85.98 lb, was diagnosed with maintenance of anaesthesia, infection prophylaxis and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal. DIPRIVAN dosage: unknown. During the same period patient was treated with ISEPACIN, PANALDINE, ASPIRIN, ALEVIATIN, LAUGHING GAS. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 04, 2006. Male patient, 35 years of age, weighting 154.3 lb, was diagnosed with sedation, induction of anaesthesia, maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: brain oedema, deep vein thrombosis, hypoxic encephalopathy, leg amputation, metastases to adrenals, metastases to lung, pulmonary function test decreased. DIPRIVAN dosage: unknown. During the same period patient was treated with MIDAZOLAM HYDROCHLORIDE, FENTANYL CITRATE, FENTANYL CITRATE, VECURONIUM BROMIDE, VECURONIUM BROMIDE. Patient died.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Sept 29, 2006. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with induction of anaesthesia, epidural anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, hyperthermia malignant, myoglobinuria, post procedural complication. DIPRIVAN dosage: unknown. During the same period patient was treated with ANAPEINE, ATROPINE SULPHATE, HYDROXYZINE HYDROCHLORIDE, VECURONIUM BROMIDE, ACETATE, MIDAZOLAM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 04, 2006. Male patient, 35 years of age, weighting 154.3 lb, was diagnosed with sedation, induction of anaesthesia, maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: brain oedema, convulsion, hypoxic encephalopathy. DIPRIVAN dosage: unknown. During the same period patient was treated with MIDAZOLAM, FENTANYL CITRATE, FENTANYL CITRATE, VECURONIUM BROMIDE, VECURONIUM BROMIDE. Patient died.
DIPRIVAN problem was reported by a Pharmacist from UNITED KINGDOM on Oct 09, 2006. Female patient, 42 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia, lung disorder. DIPRIVAN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 18, 2006. Male patient, 14 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: hyperthermia malignant. DIPRIVAN dosage: unknown. Patient died.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Oct 18, 2006. Female patient, 16 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: hyperthermia malignant. DIPRIVAN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 18, 2006. Male patient, 67 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, post procedural complication. DIPRIVAN dosage: unknown. During the same period patient was treated with SEVOFLURANE, FENTANYL CITRATE. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Oct 18, 2006. Female patient, 14 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: hyperthermia malignant. DIPRIVAN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 25, 2006. Female patient, 55 years of age, weighting 121.3 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, hypotension and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema, toxic epidermal necrolysis. DIPRIVAN dosage: unknown. During the same period patient was treated with VECURONIUM BROMIDE, OXYGEN MEDICAL USE, NITROUS OXIDE W, SEVOFLURANE, NITROPRUSSIDE. Patient died.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Sept 29, 2006. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, epidural anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood pressure increased, hyperthermia malignant, myoglobinuria. DIPRIVAN dosage: unknown. During the same period patient was treated with ANAPEINE, ATROPINE SULPHATE, VAGOSTIGMIN. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 26, 2006. Female patient, 86 years of age, was diagnosed with induction and maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. DIPRIVAN dosage: unknown. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Oct 25, 2006. Female patient, 70 years of age, weighting 85.98 lb, was diagnosed with maintenance of anaesthesia, hypertension, induction of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: swelling face, tongue oedema. DIPRIVAN dosage: unknown. During the same period patient was treated with MIDAZOLAM, FENTANYL CITRATE. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 18, 2006. Male patient, 67 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, electrocardiogram st segment abnormal, post procedural complication, restlessness, stress cardiomyopathy. DIPRIVAN dosage: unknown. During the same period patient was treated with SEVOFLURANE, FENTANYL CITRATE. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from FRANCE on Nov 08, 2006. Female patient, 17 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, metabolic acidosis, renal failure acute, rhabdomyolysis, shock. DIPRIVAN dosage: unknown. Patient recovered.
Physician from JAPAN reported DIPRIVAN problem on Feb 13, 2006. Male patient, weighting 242.5 lb, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: anaemia, continuous haemodiafiltration, cyanosis, neisseria infection, post procedural complication, pyrexia, renal failure, respiratory failure. DIPRIVAN dosage: 15-20 ML/HR. During the same period patient was treated with MIDAZOLAM, LEPETAN, NITROGLYCERIN, HERBESSER, BUFFERIN, NORVASC, NITROPEN. Patient recovered.
DIPRIVAN problem was reported by a Physician from JAPAN on Nov 06, 2006. Male patient, 64 years of age, was diagnosed with induction and maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. DIPRIVAN dosage: unknown. During the same period patient was treated with KETAMINE, ALTAT, RHYTHMY, FENTANYL CITRATE, MUSCULAX, MARCAINE, HALOSPOR, DECADRON. Patient recovered.
Physician from JAPAN reported DIPRIVAN problem on Nov 06, 2006. Male patient, 64 years of age, was diagnosed with induction and maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, post procedural nausea. DIPRIVAN dosage: unknown. During the same period patient was treated with KETAMINE, ALTAT, RHYTHMY, FENTANYL, MUSCULAX, MARCAINE, HALOSPOR, DECADRON. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Oct 25, 2006. Female patient, 80 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, epidural anaesthesia, hypertension and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, pulse absent. DIPRIVAN dosage: unknown. During the same period patient was treated with ANAPEINEECTION, BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE, NIFEDIPINE, VALSARTAN. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 26, 2006. Male patient, 83 years of age, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. DIPRIVAN dosage: unknown. During the same period patient was treated with RISPERDAL, CIPROFLOXACIN, LASIX, FAMOTIDINE. Patient recovered.
DIPRIVAN problem was reported by a Pharmacist from FRANCE on Nov 08, 2006. Female patient, 17 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, metabolic acidosis, renal failure acute, rhabdomyolysis, shock. DIPRIVAN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 25, 2006. Female patient, 80 years of age, was diagnosed with induction of anaesthesia, maintenance of anaesthesia, epidural anaesthesia, hypertension and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, pulse absent. DIPRIVAN dosage: unknown. During the same period patient was treated with ANAPEINEECTION, BUTORPHANOL TARTRATE, BUTORPHANOL TARTRATE, NIFEDIPINE, VALSARTAN. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Sept 06, 2006. Female patient, 32 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, hyponatraemia, metabolic acidosis, procedural complication, water intoxication. DIPRIVAN dosage: unknown. During the same period patient was treated with FENTANEST. Patient recovered.
Physician from JAPAN reported DIPRIVAN problem on Nov 06, 2006. Male patient, weighting 172.0 lb, was diagnosed with induction and maintenance of anaesthesia, analgesic effect, hypotonia, local anaesthesia, infection prophylaxis and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, hepatic function abnormal, mixed hepatocellular-cholestatic injury, operative haemorrhage, procedural complication, white blood cell count increased. DIPRIVAN dosage: 2.5-3.0 UG/ML. During the same period patient was treated with ALTAT, RHYTHMY, FENTANEST, MUSCULAX, MARCAINE, HALOSPOR. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Physician from JAPAN on Nov 24, 2006. Female patient, 36 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: urticaria. DIPRIVAN dosage: unknown. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Oct 11, 2006. Female patient, weighting 81.57 lb, was diagnosed with spinal anaesthesia, epidural anaesthesia, ankle fracture, gastritis, sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: foaming at mouth, non-cardiogenic pulmonary oedema, obstructive airways disorder. DIPRIVAN dosage: unknown. During the same period patient was treated with MARCAINE HYDROCHLORIDE PRESERVATIVE FREE, XYLOCAINE W, LOXONIN, MUCOSTA, STADOL, DORMICUM, OXYGEN. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from FRANCE on Dec 05, 2006. Female patient, 67 years of age, weighting 110.2 lb, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. DIPRIVAN dosage: unknown. During the same period patient was treated with BETADINE, BLEU PATENTE V GUERBET, SUFENTA, ACETAMINOPHEN, SEVORANE. Patient recovered.
Physician from CHINA reported DIPRIVAN problem on Nov 28, 2006. Female patient, weighting 143.3 lb, was diagnosed with abortion induced and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: asthenia, cold sweat, heart rate decreased, hyperhidrosis, listless, pallor, vagus nerve disorder, vomiting. DIPRIVAN dosage: unknown. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Oct 18, 2006. Female patient, weighting 119.0 lb, was diagnosed with sedation, induction of anaesthesia, maintenance of anaesthesia, vomiting, sinus tachycardia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase decreased, delayed recovery from anaesthesia, glasgow coma scale abnormal, hyperkalaemia, hyperthermia malignant, myoglobinuria, pyrexia. DIPRIVAN dosage: unknown. During the same period patient was treated with PRIMPERAN, PENTAZOCINE LACTATE, HERBESSER. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported DIPRIVAN problem on Dec 06, 2006. Male patient, 70 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, haemorrhagic diathesis, platelet count decreased, rash, white blood cell count decreased. DIPRIVAN dosage: unknown. Patient recovered.
DIPRIVAN problem was reported by a Physician from JAPAN on Nov 24, 2006. Female patient, weighting 126.8 lb, was diagnosed with sedation, local anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: anaphylactoid reaction. DIPRIVAN dosage: unknown. During the same period patient was treated with XYLOCAINE. Patient recovered.
Health Professional from FRANCE reported DIPRIVAN problem on Dec 11, 2006. Female patient, 46 years of age, was diagnosed with headache and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: protein s deficiency, pulmonary embolism, superior sagittal sinus thrombosis. DIPRIVAN dosage: unknown. During the same period patient was treated with ZOMIG, ORAL CONTRACEPTIVE. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from BELGIUM on May 11, 2006. Male patient, 30 years of age, weighting 116.8 lb, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood creatine phosphokinase increased, blood lactic acid increased, electrocardiogram t wave inversion, propofol infusion syndrome, rhabdomyolysis, sinus arrhythmia, troponin t increased. DIPRIVAN dosage: unknown. During the same period patient was treated with ULTIVA. Patient recovered.
Consumer or non-health professional from LUXEMBOURG reported DIPRIVAN problem on Dec 14, 2006. Female patient, child 3 years of age, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: propofol infusion syndrome. DIPRIVAN dosage: VARIABLE DOSE, HIGHEST 10ML/HOUR. Patient died on 07/01/2005.
DIPRIVAN problem was reported by a Health Professional from UNITED STATES on Dec 18, 2006. Female patient, weighting 44.97 lb, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: body temperature increased, cough, post procedural complication. DIPRIVAN dosage: 140MG BOLUS IV BOLUS. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported DIPRIVAN problem on Dec 18, 2006. Female patient, weighting 43.87 lb, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: body temperature increased, post procedural complication. DIPRIVAN dosage: 60MG BOLUS IV BOLUS. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Physician from JAPAN on Nov 06, 2006. Male patient, weighting 172.0 lb, was diagnosed with induction and maintenance of anaesthesia, analgesic effect, hypotonia, local anaesthesia, infection prophylaxis and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cholestasis, condition aggravated, hepatocellular damage, liver disorder. DIPRIVAN dosage: 2.5-3.0 UG/ML. During the same period patient was treated with ALTAT, RHYTHMY, FENTANEST, MUSCULAX, MARCAINE, HALOSPOR. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported DIPRIVAN problem on Dec 06, 2006. Male patient, 76 years of age, was diagnosed with induction of anaesthesia, epidural anaesthesia, hypotonia, analgesic effect and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: anaphylactoid reaction, haemorrhagic diathesis. DIPRIVAN dosage: unknown. During the same period patient was treated with SULPERAZON, MARCAINE, MUSCULAX, FENTANEST. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Dec 22, 2006. Male patient, 65 years of age, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: blood urea increased, delayed recovery from anaesthesia, hepatic function abnormal, renal impairment. DIPRIVAN dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Dec 11, 2006. Female patient, 14 years of age, weighting 119.0 lb, was diagnosed with bleeding time prolonged, blood pressure increased, brain oedema, cerebral vasoconstriction, hypotonia, induction of anaesthesia, infection prophylaxis and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, body temperature decreased, delayed recovery from anaesthesia, depressed level of consciousness, hepatic trauma, hyperkalaemia, hypoperfusion, liver disorder. DIPRIVAN dosage: unknown. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Physician from CHINA on Dec 07, 2006. Female patient, 27 years of age, weighting 143.3 lb, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: asthenia, cold sweat, hyperhidrosis, listless, pallor, post procedural complication, uterine hypotonus, vagus nerve disorder. DIPRIVAN dosage: 110 MG. Patient recovered.
Health Professional from BELGIUM reported DIPRIVAN problem on Dec 18, 2006. Male patient, 30 years of age, weighting 116.8 lb, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood creatine phosphokinase increased, blood lactic acid increased, electrocardiogram t wave inversion, lung infection pseudomonal, propofol infusion syndrome, respiratory failure, rhabdomyolysis, sinus arrhythmia. DIPRIVAN dosage: 5.7 MG/KG/HR,INTRAVENOUS. During the same period patient was treated with ULTIVA. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from FRANCE on Dec 18, 2006. Female patient, 46 years of age, was diagnosed with headache and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, superior sagittal sinus thrombosis. DIPRIVAN dosage: unknown. During the same period patient was treated with ZOMIG, ORAL CONTRACEPTIVE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from LUXEMBOURG reported DIPRIVAN problem on Dec 19, 2006. Female patient, child 3 years of age, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: propofol infusion syndrome. DIPRIVAN dosage: VARIABLE DOSE, HIGHEST 10ML/HOUR, INTRAVENOUS. Patient died.
DIPRIVAN problem was reported by a Health Professional from JAPAN on June 21, 2007. Female patient, 71 years of age, weighting 127.9 lb, was diagnosed with induction of anaesthesia, maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: delayed recovery from anaesthesia, fat embolism. DIPRIVAN dosage: unknown. During the same period patient was treated with VECURONIUM BROMIDE, FENTANEST, OXYGEN MEDICAL USE, NITROUS OXIDE W, SEVOFLURANE. Patient recovered.
Health Professional from UNITED STATES reported DIPRIVAN problem on July 27, 2007. Female patient, 30 years of age, weighting 130.0 lb, was diagnosed with induction of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: convulsion, glasgow coma scale abnormal, hypertension, hypertonia, mydriasis, post procedural complication, postictal state, posturing, unresponsive to stimuli. DIPRIVAN dosage: 150 MG IV. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from UNITED STATES on July 20, 2007. Male patient, 66 years of age, was diagnosed with sedation, polymyositis and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, blood uric acid increased, diastolic dysfunction, gouty tophus, haemodialysis, mitochondrial toxicity, myopathy toxic, oliguria. DIPRIVAN dosage: unknown. During the same period patient was treated with SIMVASTATIN, COLCHICUM JTL LIQ, CYCLOSPORINE, METHYLPREDNISOLONE, PREDNISONE, MYCOPHENOLATE, INSULIN. Patient was hospitalized and became disabled. Patient died.
Health Professional from FRANCE reported DIPRIVAN problem on July 26, 2007. Male patient, 57 years of age, was diagnosed with prophylaxis and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. DIPRIVAN dosage: unknown. During the same period patient was treated with CELOCURIN, NIMBEX, CHLORHEXIDINE GLUCONATE, SUFENTA, TRIATEC. Patient recovered.
DIPRIVAN problem was reported by a Physician from JAPAN on July 25, 2007. Female patient, 42 years of age, was diagnosed with induction and maintenance of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: delayed recovery from anaesthesia. DIPRIVAN dosage: unknown. During the same period patient was treated with REMIFENTANIL HYDROCHLORIDE, REMIFENTANIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Pharmacist from FRANCE reported DIPRIVAN problem on July 27, 2007. Female patient, 17 years of age, weighting 121.3 lb, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, metabolic acidosis, off label use, propofol infusion syndrome, renal failure acute, rhabdomyolysis, shock. DIPRIVAN dosage: unknown. During the same period patient was treated with MIDAZOLAM HYDROCHLORIDE, ACYCLOVIR. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Female patient, child 3 years of age, was diagnosed with angiogram and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, hypotension, metabolic acidosis, overdose, post procedural complication, propofol infusion syndrome, tachycardia. DIPRIVAN dosage: 80 MG. Patient recovered.
Health Professional from UNITED STATES reported DIPRIVAN problem on July 26, 2007. Female patient, 30 years of age, weighting 291.0 lb, was diagnosed with cystopexy and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: amnesia, glasgow coma scale abnormal, muscle rigidity, myalgia, posturing, unresponsive to stimuli. DIPRIVAN dosage: 180 MG, INTRAVENOUS; INTRAVENOUS. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Pharmacist from FRANCE on July 27, 2007. Female patient, 17 years of age, weighting 121.3 lb, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, metabolic acidosis, off label use, propofol infusion syndrome, renal failure acute, rhabdomyolysis, shock. DIPRIVAN dosage: unknown. During the same period patient was treated with MIDAZOLAM, ACYCLOVIR. Patient recovered.
Physician from UNITED STATES reported DIPRIVAN problem on Aug 15, 2007. Male patient, 31 years of age, weighting 176.4 lb, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: influenza like illness, post procedural complication. DIPRIVAN dosage: 200 MG ONCE IV BOLUS. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Physician from UNITED STATES on Aug 13, 2007. Male patient, 31 years of age, was diagnosed with induction of anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: chills, influenza like illness, myalgia, tremor. DIPRIVAN dosage: 10 MG/CC. Patient was hospitalized. Patient recovered.
Health Professional from JAPAN reported DIPRIVAN problem on Aug 28, 2007. Male patient, 51 years of age, was treated with DIPRIVAN. DIPRIVAN dosage: 10ML/HR. Patient died.
DIPRIVAN problem was reported by a Physician from UNITED STATES on Aug 30, 2007. Male patient was diagnosed with colonoscopy and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: chills, postoperative fever. DIPRIVAN dosage: 250MG IV. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DIPRIVAN problem on Aug 06, 2007. Female patient, 72 years of age, was diagnosed with anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: asthma, fatigue, no therapeutic response. DIPRIVAN dosage: unknown. During the same period patient was treated with FLOVENT, VITAMIN B12, NOVALOG INSULIN, PREMARIN, PRILOSEC, VERAPAMIL, XANAX, ZOLOFT. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from JAPAN on Aug 29, 2007. Male patient, 51 years of age, was treated with DIPRIVAN. DIPRIVAN dosage: 10ML/HR. Patient died.
Physician from JAPAN reported DIPRIVAN problem on Aug 27, 2007. Female patient, weighting 112.4 lb, was diagnosed with induction and maintenance of anaesthesia, epilepsy, pain, hypotonia, bradycardia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness. DIPRIVAN dosage: unknown. During the same period patient was treated with ULTIVA, TEGRETOL, NAROPIN, MUSCULAX, FENTANEST, ATROPINE. Patient recovered.
DIPRIVAN problem was reported by a Health Professional from FRANCE on Aug 28, 2007. Female patient, 39 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: eosinophilia, rash erythematous. DIPRIVAN dosage: unknown. During the same period patient was treated with SUFENTA, TRACRIUM, KETALAR, CEFOTAXIME PANPHARMA, CEFOXITINE PANPHARMA. Patient was hospitalized. Patient recovered.
Physician from UKRAINE reported DIPRIVAN problem on Sept 06, 2007. Male patient, 49 years of age, was diagnosed with anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: bradycardia, hypotension. DIPRIVAN dosage: unknown. During the same period patient was treated with FENTANIL. Patient died on 09/01/2007.
DIPRIVAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2007. Female patient, 72 years of age, was diagnosed with anaesthesia and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: asthma, bronchospasm, concomitant disease aggravated, fatigue, no therapeutic response. DIPRIVAN dosage: unknown. During the same period patient was treated with FLOVENT, VITAMIN B12, NOVALOG INSULIN, PREMARIN, PRILOSEC, VERAPAMIL, XANAX, ZOLOFT. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported DIPRIVAN problem on Sept 11, 2007. Female patient, 33 years of age, weighting 120.0 lb, was diagnosed with colonoscopy and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: aspiration, injection site pain, oxygen saturation decreased, pneumonia, procedural complication, sepsis. DIPRIVAN dosage: unknown. Patient was hospitalized. Patient recovered.
DIPRIVAN problem was reported by a Pharmacist from UNITED STATES on Sept 11, 2007. Female patient, weighting 156.5 lb, was diagnosed with sedation and was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: post procedural complication, pyrexia. DIPRIVAN dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported DIPRIVAN problem on Sept 25, 2007. Female patient, 77 years of age, was treated with DIPRIVAN. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, atrioventricular block, shock. DIPRIVAN dosage: unknown. During the same period patient was treated with ATROPINE, MUSCULAX. Patient recovered.
Showing 1-75 of 142 Next >